GDNF is identified as being important for preserving the health of dopaminergic neurons, with implications for Parkinson’s disease [105,106,107,108,109], but there appears to be limited clinical success of exogenously administered GDNF [110,111]. This evidence concerns the gene GDNF and Parkinson disease.